Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Noninvasive Prenatal Testing (NIPT) market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Noninvasive Prenatal Testing (NIPT) market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.
Segmented by Category
DNA Testing
Blood Testing
Segmented by End User/Segment
Clinic
Hospital
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Key manufacturers included in this survey
Progenity
Natera
Intergrated Genetics
Illuminansyl
Counsyl
Table of Contents1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Noninvasive Prenatal Testing (NIPT) Market Status and Forecast (2016-2027) 1.3.2 Global Noninvasive Prenatal Testing (NIPT) Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis2 Global Noninvasive Prenatal Testing (NIPT) Supply by Company 2.1 Global Noninvasive Prenatal Testing (NIPT) Sales Volume by Company 2.2 Global Noninvasive Prenatal Testing (NIPT) Sales Value by Company 2.3 Global Noninvasive Prenatal Testing (NIPT) Price by Company 2.4 Noninvasive Prenatal Testing (NIPT) Production Location and Sales Area of Main Manufacturers 2.5 Trend of Concentration Rate3 Global and Regional Noninvasive Prenatal Testing (NIPT) Market Status by Category 3.1 Noninvasive Prenatal Testing (NIPT) Category Introduction 3.1.1 DNA Testing 3.1.2 Blood Testing 3.2 Global Noninvasive Prenatal Testing (NIPT) Market by Category 3.2.1 Global Noninvasive Prenatal Testing (NIPT) Sales Volume by Category (2016-2021) 3.2.2 Global Noninvasive Prenatal Testing (NIPT) Sales Value by Category (2016-2021) 3.2.3 Global Noninvasive Prenatal Testing (NIPT) Price by Category (2016-2021) 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category4 Global and Regional Noninvasive Prenatal Testing (NIPT) Market Status by End User/Segment 4.1 Noninvasive Prenatal Testing (NIPT) Segment by End User/Segment 4.1.1 Clinic 4.1.2 Hospital 4.2 Global Noninvasive Prenatal Testing (NIPT) Market by End User/Segment 4.2.1 Global Noninvasive Prenatal Testing (NIPT) Sales Volume by End User/Segment (2016-2021) 4.2.2 Global Noninvasive Prenatal Testing (NIPT) Sales Value by End User/Segment (2016-2021) 4.2.3 Global Noninvasive Prenatal Testing (NIPT) Price by End User/Segment (2016-2021) 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment5 Global Noninvasive Prenatal Testing (NIPT) Market Status by Region 5.1 Global Noninvasive Prenatal Testing (NIPT) Market by Region 5.1.1 Global Noninvasive Prenatal Testing (NIPT) Sales Volume by Region 5.1.2 Global Noninvasive Prenatal Testing (NIPT) Sales Value by Region 5.2 North America Noninvasive Prenatal Testing (NIPT) Market Status 5.3 Europe Noninvasive Prenatal Testing (NIPT) Market Status 5.4 Asia Pacific Noninvasive Prenatal Testing (NIPT) Market Status 5.5 Central & South America Noninvasive Prenatal Testing (NIPT) Market Status 5.6 Middle East & Africa Noninvasive Prenatal Testing (NIPT) Market Status6 North America Noninvasive Prenatal Testing (NIPT) Market Status 6.1 North America Noninvasive Prenatal Testing (NIPT) Market by Country 6.1.1 North America Noninvasive Prenatal Testing (NIPT) Sales Volume by Country (2016-2021) 6.1.2 North America Noninvasive Prenatal Testing (NIPT) Sales Value by Country (2016-2021) 6.2 United States 6.3 Canada 6.4 Mexico7 Europe Noninvasive Prenatal Testing (NIPT) Market Status 7.1 Europe Noninvasive Prenatal Testing (NIPT) Market by Country 7.1.1 Europe Noninvasive Prenatal Testing (NIPT) Sales Volume by Country (2016-2021) 7.1.2 Europe Noninvasive Prenatal Testing (NIPT) Sales Value by Country (2016-2021) 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain8 Asia Pacific Noninvasive Prenatal Testing (NIPT) Market Status 8.1 Asia Pacific Noninvasive Prenatal Testing (NIPT) Market by Country 8.1.1 Asia Pacific Noninvasive Prenatal Testing (NIPT) Sales Volume by Country (2016-2021) 8.1.2 Asia Pacific Noninvasive Prenatal Testing (NIPT) Sales Value by Country (2016-2021) 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia9 Central & South America Noninvasive Prenatal Testing (NIPT) Market Status 9.1 Central & South America Noninvasive Prenatal Testing (NIPT) Market by Country 9.1.1 Central & South America Noninvasive Prenatal Testing (NIPT) Sales Volume by Country (2016-2021) 9.1.2 Central & South America Noninvasive Prenatal Testing (NIPT) Sales Value by Country (2016-2021) 9.2 Brazil 9.3 Argentina 9.4 Colombia10 Middle East & Africa Noninvasive Prenatal Testing (NIPT) Market Status 10.1 Middle East & Africa Noninvasive Prenatal Testing (NIPT) Market by Country 10.1.1 Middle East & Africa Noninvasive Prenatal Testing (NIPT) Sales Volume by Country (2016-2021) 10.1.2 Middle East & Africa Noninvasive Prenatal Testing (NIPT) Sales Value by Country (2016-2021) 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia11 Supply Chain and Manufacturing Cost Analysis 11.1 Supply Chain Analysis 11.2 Production Process Chart Analysis 11.3 Raw Materials and Key Suppliers Analysis 11.3.1 Raw Materials Introduction 11.3.2 Raw Materials Key Suppliers List 11.4 Noninvasive Prenatal Testing (NIPT) Manufacturing Cost Analysis 11.5 Noninvasive Prenatal Testing (NIPT) Sales Channel and Distributors Analysis 11.5.1 Noninvasive Prenatal Testing (NIPT) Sales Channel 11.5.2 Noninvasive Prenatal Testing (NIPT) Distributors 11.6 Noninvasive Prenatal Testing (NIPT) Downstream Major Buyers12 Global Noninvasive Prenatal Testing (NIPT) Market Forecast by Category and by End User/Segment 12.1 Global Noninvasive Prenatal Testing (NIPT) Sales Volume and Sales Value Forecast (2022-2027) 12.2 Global Noninvasive Prenatal Testing (NIPT) Forecast by Category 12.2.1 Global Noninvasive Prenatal Testing (NIPT) Sales Volume Forecast by Category 12.2.2 Global Noninvasive Prenatal Testing (NIPT) Sales Value Forecast by Category 12.2.3 Global Noninvasive Prenatal Testing (NIPT) Price Forecast by Category 12.3 Global Noninvasive Prenatal Testing (NIPT) Forecast by End User/Segment 12.3.1 Global Noninvasive Prenatal Testing (NIPT) Sales Volume Forecast by End User/Segment 12.3.2 Global Noninvasive Prenatal Testing (NIPT) Sales Value Forecast by End User/Segment 12.3.3 Global Noninvasive Prenatal Testing (NIPT) Price Forecast by End User/Segment13 Global Noninvasive Prenatal Testing (NIPT) Market Forecast by Region/Country 13.1 Global Noninvasive Prenatal Testing (NIPT) Market Forecast by Region (2022-2027) 13.1.1 Global Noninvasive Prenatal Testing (NIPT) Sales Volume Forecast by Region (2022-2027) 13.1.2 Global Noninvasive Prenatal Testing (NIPT) Sales Value Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast14 Key Participants Company Information 14.1 Progenity 14.1.1 Company Information 14.1.2 Noninvasive Prenatal Testing (NIPT) Product Introduction 14.1.3 Progenity Noninvasive Prenatal Testing (NIPT) Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.1.4 SWOT Analysis 14.2 Natera 14.2.1 Company Information 14.2.2 Noninvasive Prenatal Testing (NIPT) Product Introduction 14.2.3 Natera Noninvasive Prenatal Testing (NIPT) Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.2.4 SWOT Analysis 14.3 Intergrated Genetics 14.3.1 Company Information 14.3.2 Noninvasive Prenatal Testing (NIPT) Product Introduction 14.3.3 Intergrated Genetics Noninvasive Prenatal Testing (NIPT) Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.3.4 SWOT Analysis 14.4 Illuminansyl 14.4.1 Company Information 14.4.2 Noninvasive Prenatal Testing (NIPT) Product Introduction 14.4.3 Illuminansyl Noninvasive Prenatal Testing (NIPT) Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.4.4 SWOT Analysis 14.5 Counsyl 14.5.1 Company Information 14.5.2 Noninvasive Prenatal Testing (NIPT) Product Introduction 14.5.3 Counsyl Noninvasive Prenatal Testing (NIPT) Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.5.4 SWOT Analysis ...15 Conclusion16 Methodology